This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (26)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN B. McDONALD, M.D.; JEWELL G. HAMRICK, M.D.

Arch Intern Med. 1948;81(1):73-84.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THERE have been many observations in medical literature in which megakaryocytes have been described as a prominent feature in pathologic conditions of the blood. The number of these cells is frequently increased in thrombocytothemia and polycythemia vera. Their presence in the bone marrow, liver, spleen and other viscera has been mentioned in numerous articles on myelogenous leukemia and various other diseases. Although the classification of leukemias by most American authors, including Bethell,¹ Downey,² Forkner,³ Kolmer,⁴ Kracke,⁵ Osgood,⁶ Levin⁷ and Wintrobe,⁸ recognizes the possibility of megakaryocytic leukemia, the specific criteria necessary for such a diagnosis are not stated in detail.

Von Boros and Korényi⁹ reported a condition in 1931 which they designated as "acute megakaryoblastic leukemia," but the authenticity of the case has been questioned by American hematologists owing to lack of sufficient data.

Lindeboom¹⁰ in 1938 noted that giant cells of megakaryocytic type were prominent features in a group of . . . [Full Text PDF of this Article]

Author Affiliations
Chief of Medical Section, W. E. Branch Clinic; Associate Pathologist, Hollywood Presbyterian Hospital LOS ANGELES

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?